Breakthrough Genomics
PrivateCompany Overview
Breakthrough Genomics is a healthcare technology company that provides AI-powered genomic data analysis and clinical interpretation software for rare disease diagnosis and cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakthrough Genomics Comparables
Compare Breakthrough Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomenon Inc. | 84% | |
| Golden Helix | 83% | |
| Gamow Labs, Inc. | 82% | |
Breakthrough Genomics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 990% MoM, reaching 1.7K.
- Nov 12, 2024
Monthly visitors grew 1150% MoM, reaching 1.3K.
Breakthrough Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Breakthrough Genomics's valuation, stock price, and market status.